Immediate Impact

55 standout
Sub-graph 1 of 24

Citing Papers

The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy
2025 Standout
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management
2025 Standout
2 intermediate papers

Works of Canan Alhan being referenced

Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts
2013

Author Peers

Author Last Decade Papers Cites
Canan Alhan 469 195 105 127 31 509
Catherine Flynn 273 134 43 95 31 525
Y Yoshida 303 110 53 157 44 508
RD Brunning 230 172 57 185 24 529
K Hirashima 288 98 50 76 44 456
G Castoldi 342 121 29 91 29 449
Christine Vaupel 341 162 39 48 18 459
Gianni Perla 223 205 18 69 22 435
Keiki Kawakami 293 106 26 125 47 475
Mónica Cabrero 375 105 21 173 32 542
V. Parlier 378 140 38 31 19 440

All Works

Loading papers...

Rankless by CCL
2026